Prediction Model and Decision Analysis for Early Recognition of SDNS/FRNS in Children
Hui Yin,Xiao Lin,Chun Gan,Han Xiao,Yaru Jiang,Xindi Zhou,Qing Yang,Wei Jiang,Mo Wang,Haiping Yang,Gaofu Zhang,Han Chan,Qiu Li
DOI: https://doi.org/10.2147/jir.s494530
IF: 4.5
2024-12-08
Journal of Inflammation Research
Abstract:Hui Yin, &ast Xiao Lin, &ast Chun Gan, Han Xiao, Yaru Jiang, Xindi Zhou, Qing Yang, Wei Jiang, Mo Wang, Haiping Yang, Gaofu Zhang, Han Chan, Qiu Li Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Han Chan; Qiu Li, Chongqing Medical University, Chongqing, People's Republic of China, Email ; Purpose: This study identified factors that identification of progression-predicting utility from steroid-sensitive nephrotic syndrome(SSNS) to steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS) in patients and developed a corresponding predictive model. Patients and Methods: This retrospective study analyzed clinical data from 756 patients aged 1 to 18 years, diagnosed with SSNS, who received treatment at the Department of Nephrology, Children's Hospital of Chongqing Medical University, between November 2007 and May 2023. We developed a shrinkage and selection operator (LASSO) - logistic regression model, which was visualized using a nomogram. The model's performance, validity, and clinical utility were evaluated through receiver operating characteristic curve analysis, confusion matrix, calibration plot, and decision curve analysis. Results: The platelet-to-lymphocyte ratio (PLR) was identified as an independent risk factor for progression, with an odds ratio (OR) of 1.01 (95% confidence interval (CI) = 1.01– 1.01, p = 0.009). Additionally, other significant factors included the time for urinary protein turned negative (OR = 1.17, 95% CI = 1.12– 1.23, p < 0.001), estimated glomerular filtration rate(eGFR) (OR = 0.99, 95% CI = 0.98– 0.99, p < 0.001), low-density lipoprotein (OR = 0.90, 95% CI = 0.83– 0.97, p = 0.006), thrombin time (OR = 1.22, 95% CI = 1.07– 1.39, p = 0.003), and neutrophil absolute counts (OR = 1.10, 95% CI = 1.02– 1.18, p = 0.009). The model's performance was assessed through internal validation, yielding an area under the curve of 0.78 (0.73– 0.82) for the training set and 0.81 (0.75– 0.87) for the validation set. Conclusion: PLR, eGFR, the time for urinary protein turned negative, low-density lipoprotein, thrombin time, and neutrophil absolute counts may be effective predictors for identifying SSNS patients at risk of progressing to SDNS/FRNS. These findings offer valuable insights for early detection and support the use of precision medicine strategies in managing SDNS/FRNS. Keywords: PLR, LASSO, SSNS, SDNS/FRNS, nomogram, prediction Idiopathic nephrotic syndrome (INS) is a prevalent glomerular disorder in children, with an annual global incidence of 1.15 to 16.90 cases per 100,000. 1 It is marked by heavy proteinuria, hypoalbuminemia, hyperlipidemia, and edema. The initial treatment involves oral prednisone (PDN), and patients are classified as either steroid-sensitive nephrotic syndrome (SSNS) or steroid-resistant nephrotic syndrome based on their response to the first four weeks of PDN therapy. 2 Approximately 80% to 90% of INS cases are SSNS. 3 However, around 50% of SSNS cases progress to steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS). Patients are diagnosed with SDNS/FRNS if they relapse within 14 days of stopping PDN, require continuous PDN to stay in remission, or experience at least two relapses in six months or three relapses in a year. 4 While SDNS/FRNS generally does not impair kidney function, 3,5,6 frequent relapses often require prolonged PDN therapy, which increases the risk of adverse effects such as behavioral changes, sleep disturbances, obesity, and comorbidities like diabetes. 6 Studies following these patients into adulthood show a high prevalence of hypertension, osteoporosis, and cataracts, all linked to chronic glucocorticoid exposure during childhood. 7–9 Although non-corticosteroid immunosuppressive medications can help reduce relapse frequency, their use is typically limited to SDNS/FRNS due to the potential for significant side effects. 10–12 This underscores the importance of early identification of SSNS patients who are at risk of progressing to SDNS/FRNS. Currently, patient response to steroid therapy remains the primary standard for clinicians diagnosing SDNS/FRNS. However, diagnosing based on recurrence frequency during PDN therapy results in PDN accumulation, which severely impacts children's quality of life. Although some research has explored factors influencin -Abstract Truncated-
immunology